Custom 3D adaptive seating (SSAP3D) for children with neuromotor dysfunction
Official title: Development and Effectiveness of the Participatory Adapted 3D Seating System (SSAP3D) and Its Impact on the Daily Performance of Children With Neuromotor Dysfunction and Their Families: Pilot Study
Run by Instituto de Investigación Sanitaria Aragón · NCT07330921 · Data updated 2026-11-12
This project will test whether a custom 3D‑printed adaptive seat (SSAP3D) helps children aged 2–6 with neuromotor dysfunction improve posture and daily functioning.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 2 Years to 6 Years |
| Sex | All |
| Enrollment | 12 (estimated) |
| Sponsor | Instituto de Investigación Sanitaria Aragón Academic / other |
| Locations | 1 site (Zaragoza, Zaragoza) |
| Status | Recruiting |
| Started | April 3, 2026 |
| Main results expected | December 30, 2026 |
| Study ends | January 8, 2027 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT07330921 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 2–6 with neuromotor dysfunction who already use an adapted seating system, have Level of Sitting Scale head control scores 3–8, and can maintain standing for at least 10 seconds (with or without assistance).
✕Probably not a fit
Children with moderate or severe cognitive impairment that prevents following instructions, those who have had recent trauma or surgery within six months, or those outside the specified age and functional criteria are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot uses a randomized crossover design in two groups who each use both the SSAP3D and a conventional seating system in opposite sequences. Investigators will scan each child, 3D‑print an individually tailored SSAP3D seat, and deliver it for six weeks of home use with two online follow‑ups. Trained physiotherapists will perform standardized quantitative evaluations at four timepoints at AIDIMO in Zaragoza to measure functional performance and posture. The study focuses on children who already use adapted seating and have specified head control and standing abilities.
Why it matters
Potential benefit: If successful, the SSAP3D could improve postural control, functional independence, and participation in daily activities for children with neuromotor dysfunction.
How similar studies have gone: Individualized seating and some 3D‑printed assistive devices have shown promising but limited evidence, and the participatory SSAP3D approach is relatively novel in this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Medical Situation of Neuromotor Disfunction * Be user of some type of adapted seating system * Age between 2-6 years * Have head control levels of 3 to 8 on the Level of Sitting Scale (LSS) * Be able to maintain a standing position for at least 10 seconds, with or without external assistance. Exclusion Criteria: * Presenting moderate or severe cognitive impairment, which generates significant difficulties in understanding the instructions given by the evaluator * Having suffered a traumatic injury o surgical process in the 6 months prior to the start of the study or during the study
Where it's running
-
AIDIMO (Asociación para la Investigación en la Discapacidad Motriz)
Zaragoza, Zaragoza, Spain Recruiting
Study contacts
- Principal investigator: Sandra Calvo, PhD — Universidad de Zaragoza
- Study coordinator: Daniel Rubio, PhD Student
- Email: danielrubio96@outlook.es
- Phone: +34 665758689
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Co-designed wrist-hand orthosis for children with neuromotor disorders
In children aged 6 to 14 with neuromotor conditions after brain injury, researchers are testing a wrist-hand brace designed with input from the kids to see if it fits better and is easier to use than their current orthosis.
-
Pelvic ultra-hypofractionated radiotherapy after surgery for high-risk endometrial cancer
This trial tests whether giving 27.5 Gy in five sessions of pelvic radiotherapy after surgery is safe and feasible for high-risk endometrial cancer patients.
-
Unified Protocol for emotional disorders in prison groups
This study tests the Unified Protocol in group sessions to help inmates with anxiety, depression, and related mood issues.
-
Using intra‑abdominal pressure and bedside ultrasound to guide decongestive treatment in heart failure
This trial will test whether using bladder pressure (intra‑abdominal pressure) measurements together with bedside ultrasound to guide IV loop diuretics helps people hospitalized with acute heart failure get rid of excess fluid more effectively than usual care.
-
Online treatment for emotional disorders in adults with long COVID-19
This study is testing if an online treatment for emotional issues can help adults with long COVID-19 feel better compared to regular care.
-
Effects of UNICLA-A2 Dairy Products on High-risk Colorectal Cancer Patients
This study is testing whether eating UNICLA-A2 dairy products can help people at high risk for colorectal cancer feel better and improve their gut health after having polyps removed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.